001     285407
005     20240304143042.0
024 7 _ |a 10.1159/000534109
|2 doi
024 7 _ |a pmid:37812925
|2 pmid
024 7 _ |a 0253-4398
|2 ISSN
024 7 _ |a 0257-2753
|2 ISSN
024 7 _ |a 1421-9845
|2 ISSN
024 7 _ |a 1421-9875
|2 ISSN
024 7 _ |a 2571-872X
|2 ISSN
037 _ _ |a DKFZ-2023-02363
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Xiao, Qiyun
|b 0
245 _ _ |a Onset time and characteristics of post-procedural bleeding after endoscopic resection of colorectal lesions: a multicenter retrospective study.
260 _ _ |a Basel
|c 2024
|b Karger
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1709559001_15776
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2024;42(1):78-86
520 _ _ |a Introduction Postprocedural bleeding is a major adverse event after endoscopic resection of colorectal lesions, but the optimal surveillance time after endoscopy is unclear. In this study, we determined onset time and characteristics of postprocedural bleeding events. Methods We retrospectively screened patients who underwent endoscopic resection of colorectal lesions at three German hospitals between 2010 and 2019 for postprocedural bleeding events using billing codes. Only patients who required re-endoscopy were included for analysis. For identified patients, we collected demographic data, clinical courses, characteristics of colorectal lesions and procedure-related variables. Factors associated with late-onset bleeding were determined by univariate and multivariate logistic regression analysis. Results From a total of 6820 patients with eligible billing codes, we identified 113 cases with postprocedural bleeding after endoscopic mucosal (61.9%) or snare resection (38.1%) that required re-endoscopy. The median size of the culprit lesion was 20 mm (interquartile range 14-30 mm). The median onset time of postprocedural bleeding was day 3 (interquartile range: 1-6.5), with 48.7% of events occurring within 48 hours. Multivariate logistic regression analysis demonstrates that continued intake of antiplatelet drugs (OR 3.98, 95% CI 0.89-10.12, p = 0.025) and flat morphology of the colorectal lesion (OR 2.98, 95% CI 1.08-8.01, p = 0.031) were associated with an increased risk for late postprocedural bleeding (> 48 h), whereas intraprocedural bleeding was associated with a decreased risk (OR 0.12, 95% CI 0.04-0.50, p = 0.001). Discussion/Conclusion Significant postprocedural bleeding can occur up to 18 days after endoscopic resection of colorectal lesions, but was predominantly observed within 48 hours. Continued intake of antiplatelet drugs and a flat morphology are associated with risk for late postprocedural bleeding.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a Eckardt, Maximilian
|b 1
700 1 _ |a Mohamed, Awsan
|b 2
700 1 _ |a Ernst, Helmut
|b 3
700 1 _ |a Behrens, Alexander
|b 4
700 1 _ |a Homann, Nils
|b 5
700 1 _ |a Hielscher, Thomas
|0 P:(DE-He78)743a4a82daab55306a2c88b9f6bf8c2f
|b 6
|u dkfz
700 1 _ |a Kähler, Georg
|b 7
700 1 _ |a Ebert, Matthias
|b 8
700 1 _ |a Belle, Sebastian
|b 9
700 1 _ |a Zhan, Tianzuo
|b 10
773 _ _ |a 10.1159/000534109
|g p. 1 - 9
|0 PERI:(DE-600)1482221-0
|n 1
|p 78-86
|t Digestive diseases
|v 42
|y 2024
|x 0253-4398
909 C O |p VDB
|o oai:inrepo02.dkfz.de:285407
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-He78)743a4a82daab55306a2c88b9f6bf8c2f
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2023
915 _ _ |a National-Konsortium
|0 StatID:(DE-HGF)0430
|2 StatID
|d 2023-10-21
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-10-21
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1120
|2 StatID
|b BIOSIS Reviews Reports And Meetings
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-10-21
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b DIGEST DIS : 2022
|d 2023-10-21
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2023-10-21
920 1 _ |0 I:(DE-He78)C060-20160331
|k C060
|l C060 Biostatistik
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C060-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21